Regueiro A, Fernández-Rodríguez D, Brugaletta S, Martín-Yuste V, Masotti M, Freixa X, Cequier A, Iñiguez A, Serruys PW, Sabaté M
Rev Esp Cardiol (Engl Ed). 2015 May;68(5):382-9, PMID: 25444377
The use of second-generation drug-eluting stents compared with bare-metal stents in patients with ST-segment elevation myocardial infarction reduces the rate of major adverse cardiac events. We aimed to evaluate the impact of sex on the performance of everolimus-eluting stents vs bare-metal stents in ST-segment elevation myocardial infarction at 2-year follow-up.
CARDIAC & CARDIOVASCULAR SYSTEMS